Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Asieris Announces Positive Interim Analysis Results in Phase II Clinical Trial of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer 2023-09-13 19:09
J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI 2023-09-13 15:58
Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China 2023-09-13 14:24
Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7 2023-09-13 13:42
AIRS Medical Inc. receives MDSAP Certification, Paving the Way for Global Expansion 2023-09-13 12:44
Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets 2023-09-13 10:30
Maxigen Biotech Inc. Wins 2023 Asia's Leading SMEs Award for Innovative Sustainability 2023-09-13 09:30
GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC. 2023-09-13 00:00
Frost & Sullivan Recognizes Suki AI with the 2023 North American Technology Leadership Award 2023-09-12 22:00
TMRW Life Sciences Receives CE Mark for the CryoRobot Select, its Next-Generation Automated Platform to Safely Manage and Store Frozen Eggs and Embryos 2023-09-12 21:01
Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week 2023-09-12 21:00
CSafe Expands Executive Team with Chief Financial Officer 2023-09-12 20:59
Datasea Announces Pricing of $2.0 Million Underwritten Public Offering 2023-09-12 20:30
New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia 2023-09-12 20:00
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration 2023-09-12 20:00
Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of Inflammation and Biological Stress Biomarkers 2023-09-12 19:57
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA 2023-09-12 19:24
The Korean Society of Ginseng confirms the effects of consuming red ginseng in the prevention and improvement of dementia 2023-09-12 17:00
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening 2023-09-12 13:03
Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures 2023-09-12 07:00
1 81 82 83 84 85 896